Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling

Archives of Pharmacal Research

Volumn 37, Issue 8, 2014, Pages 1086-1095

  Zhan, Yingzhuan ^a   Chen, Yinnan ^a   Liu, Rui ^a   Zhang, Han ^a   Zhang, Yanmin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer; EGFR signaling; Natural products; Paclitaxel; Synergism

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; PACLITAXEL; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ANIMAL; APOPTOSIS; CELL PROLIFERATION; DRUG EFFECTS; DRUG POTENTIATION; DRUG SCREENING; FEMALE; FLOW CYTOMETRY; HUMAN; INBRED MOUSE STRAIN; MCF 7 CELL LINE; METABOLISM; SIGNAL TRANSDUCTION;

ADJUVANTS, PHARMACEUTIC; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; CURCUMIN; DRUG SYNERGISM; FEMALE; FLOW CYTOMETRY; HUMANS; MCF-7 CELLS; MICE, INBRED STRAINS; PACLITAXEL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84889071343     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0311-3     Document Type: Article

References (29)

1. Aggarwal, B.B. 1995. Activation of transcription factor NF-kappaB is Suppressed by curcumin (Diferuloylmethane). Journal of Biological Chemistry 270: 24995-25000.
2. Athar, M., J.H. Back, X. Tang, K.H. Kim, L. Kopelovich, D.R. Bickers, and A.L. Kim. 2007. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicology and Applied Pharmacology 224: 274-283.
3. Banerjee, M., P. Singh, and D. Panda. 2010. Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells. FEBS Journal 277: 3437-3448.
4. Chao, J.I., W.C. Su, and H.F. Liu. 2007. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Molecular Cancer Therapeutics 6: 3039-3048.
5. Chen, Q., S. Ganapathy, K.P. Singh, S. Shankar, and R.K. Srivastava. 2010. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS ONE 5: e15288.
6. Chou, T.C., and P. Talalay. 1984. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation 22: 27-55.
7. Clark, C.A., M.D. Mceachern, S.H. Shah, Y. Rong, X. Rong, C.L. Smelley, G.C. Caldito, F.W. Abreo, and C.O. Nathan. 2010. Curcumin inhibits carcinogen and nicotine-induced mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma. Cancer Prevention Research 3: 1586-1595.
8. Cotter, T.G. 2009. Apoptosis and cancer: The genesis of a research field. Nature Reviews Cancer 9: 501-507.
9. Dhillon, N., B.B. Aggarwal, R.A. Newman, R.A. Wolff, A.B. Kunnumakkara, J.L. Abbruzzese, C.S. Ng, V. Badmaev, and R. Kurzrock. 2008. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research 14: 4491-4499.
10. Frbmont, L. 2000. Biological effects of resveratrol. Life Sciences 66: 663-673.
11. Gupta, S.C., J.H. Kim, S. Prasad, and B.B. Aggarwal. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer and Metastasis Reviews 29: 405-434.
12. Huang, W.S., Y.H. Kuo, C.C. Chin, J.Y. Wang, H.R. Yu, J.M. Sheen, S.Y. Tung, C.H. Shen, T.C. Chen, M.L. Sung, H.F. Liang, and H.C. Kuo. 2012. Proteomic analysis of the effects of baicalein on colorectal cancer cells. Proteomics 12: 810-819.
13. Johnson, J.J., and H. Mukhtar. 2007. Curcumin for chemoprevention of colon cancer. Cancer Letters 255: 170-181.
14. Li-Weber, M. 2009. New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treatment Reviews 35: 57-68.
15. Maier-Lenz, H., B. Hauns, B. Haering, J. Koetting, K. Mross, C. Unger, T. Bauknecht, A. du Bois, H.G. Meerpohl, N. Hollaender, and K. Diergarten. 1997. Phase I study of paclitaxel administered as a 1-hour infusion: Toxicity and pharmacokinetics. Seminars in Oncology 24(Suppl. 19): 16-19.
16. Miocinovic, R., N.P. McCabe, R.W. Keck, J. Jankun, J.A. Hampton, and S.H. Selman. 2005. In vivo and in vitro effect of baicalein on human prostate cancer cells. International Journal of Oncology 26: 241-246.
17. Nagaraju, G.P., S. Aliya, S.F. Zafar, R. Basha, R. Diaz, and B.F. El-Rayes. 2012. The impact of curcumin on breast cancer. Integrative Biology (Cambridge) 4: 996-1007.
18. Newman, D.J., G.M. Cragg, and K.M. Snader. 2003. Natural products as sources of new drugs over the period 1981-2002. Journal of Natural Products 66: 1022-1037.
19. Nicoletti, M.I., V. Lucchini, G. Massazza, B.J. Abbott, M. D'Incalci, and R. Giavazzi. 1993. Antitumor activity of taxol (NSC-125973) in human ovarian carcinomas growing in the peritoneal cavity of nude mice. Annals of Oncology 4: 151-155.
20. Perez, E.A. 1998. Paclitaxel in breast cancer. Oncologist 3: 373-389.
21. Saydmohammed, M., D. Joseph, and V. Syed. 2010. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells. Journal of Cellular Biochemistry 110: 447-456.
22. Sharma, R.A., S.A. Euden, S.L. Platton, D.N. Cooke, A. Shafayat, H.R. Hewitt, T.H. Marczylo, B. Morgan, D. Hemingway, S.M. Plummer, M. Pirmohamed, A.J. Gescher, and W.P. Steward. 2004. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clinical Cancer Research 10: 6847-6854.
23. Shehzad, A., F. Wahid, and Y.S. Lee. 2010. Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials. Archiv der Pharmazie 343: 489-499.
24. Simon, H.U., A. Haj-Yehia, and F. Levi-Schaffer. 2000. Role of reactive oxygen species (ROS). Apoptosis 5: 415-418.
25. Sparano, J.A., M. Wang, S. Martino, V. Jones, E.A. Perez, T. Saphner, A.C. Wolff, G.W. Sledge, W.C. Wood, and N.E. Davidson. 2008. Weekly paclitaxel in the adjuvant treatment of breast cancer. New England Journal of Medicine 358: 1663-1671.
26. Sun, X.D., X.E. Liu, and D.S. Huang. 2012. Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression. Molecular Medicine Reports 6: 1267-1270.
27. Takahashi, H., M.C. Chen, H. Pham, E. Angst, J.C. King, J. Park, E.Y. Brovman, H. Ishiguro, D.M. Harris, H.A. Reber, O.J. Hines, A.S. Gukovskaya, V.L. Go, and G. Eibl. 2011. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochimica et Biophysica Acta 1813: 1465-1474.
28. Wang, L., Y. Ling, Y. Chen, C.L. Li, F. Feng, Q.D. You, N. Lu, and Q.L. Guo. 2010. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Letters 297: 42-48.
29. Wu, B., J. Li, D. Huang, W. Wang, Y. Chen, Y. Liao, X. Tang, H. Xie, and F. Tang. 2011. Baicalein mediates inhibition of migration. BMC Cancer 11: 527.